Communications mentioning Evusheld between Professor James Palmer and the Chief Medical Officer
Dear Department of Health and Social Care,
For the period 1 July 2022 to 6 September please provide:
All papers, emails (whether a primary preparer, recipient or cc’d) or other electronic communications between Professor James Palmer and the Chief Medical Officer in which Evusheld (i.e. the combination of tixagevimab and cilgavimab, AZD7742 or any other name that is used by the DHSC for this) is mentioned.
Yours faithfully,
Louise Bicknell
Dear Ms Bicknell,
Please find attached the Department of Health and Social Care's response
to your recent FOI request (our ref: FOI-1421237).
Yours sincerely,
Freedom of Information Team
Department of Health and Social Care
Dear Department of Health and Social Care,
Thank you for your response
Please can you advise which NHS authority I should seek this information from.
Yours faithfully,
Louise Bicknell
Our ref: DE-1423432
Dear Ms Bicknell,
Thank you for your correspondence of 26 October about your freedom of
information request case FOI-1421237. I have been asked to reply.
The Department of Health and Social Care is unable to advise which NHS
organisation may hold this information.
I am sorry that I am unable to assist.
Yours sincerely,
K Jarvis
Ministerial Correspondence and Public Enquiries
Department of Health and Social Care
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now
Louise Bicknell left an annotation ()
DHSC say they do not hold this information but do not advise who dies, hence my follow up request. In the interim I have followed this with an FOI to NHS England